Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Biotech is Zen Rated F and is the 140th ranked industry out of 146 stock market industries

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
PMVP	PMV PHARMACEUTICALS INC	$63.46M	-69.00%	-62.70%	-89.03%	-103.90%	0.10	11.14	N/A	N/A	N/A
ASBP	ASPIRE BIOPHARMA HOLDINGS INC	$7.77M	N/A	-398.00%	-48.57%	89.70%	0.84	2.26	16.30%	-34,039.70%	-5,573.01%
TNYA	TENAYA THERAPEUTICS INC	$155.81M	-80.60%	-65.20%	-70.17%	-170.00%	0.27	5.75	100.00%	-36,891.10%	-36,891.11%
ACOG	ALPHA COGNITION INC	$141.53M	-54.10%	-41.80%	-38.00%	-508.80%	0.21	12.64	84.40%	-232.20%	-224.05%
CBUS	CIBUS INC	$103.81M	-225.60%	-31.10%	-21.00%	-23.10%	8.14	2.37	100.00%	-2,366.30%	-1,520.35%
GLUE	MONTE ROSA THERAPEUTICS INC	$1.88B	-41.00%	-25.90%	-19.82%	-39.40%	0.41	9.54	100.00%	-302.70%	-307.04%
HURA	TUHURA BIOSCIENCES INC	$137.55M	-154.00%	-105.40%	-128.06%	-867.00%	0.28	1.15	N/A	N/A	N/A
TRDA	ENTRADA THERAPEUTICS INC	$300.47M	-51.20%	-42.20%	-52.21%	-48.90%	0.24	13.90	100.00%	-2,895.10%	-2,878.29%
KYTX	KYVERNA THERAPEUTICS INC	$513.11M	-81.90%	-64.90%	-68.29%	-95.20%	0.31	8.15	N/A	N/A	N/A
NKTX	NKARTA INC	$202.47M	-30.90%	-24.20%	-28.24%	-23.70%	0.30	12.96	N/A	N/A	N/A
COGT	COGENT BIOSCIENCES INC	$6.51B	-83.30%	-55.80%	-41.42%	-67.00%	0.49	15.14	N/A	N/A	N/A
MCRB	SERES THERAPEUTICS INC	$68.56M	-127.30%	-34.50%	-47.72%	-32.10%	3.44	1.65	100.00%	-4,088.80%	-4,088.84%
NBP	NOVABRIDGE BIOSCIENCES	$189.32M	-20.90%	-19.40%	-19.80%	-73.60%	0.13	8.09	N/A	N/A	N/A
ELAB	PMGC HOLDINGS INC	$5.18M	-117.00%	-70.30%	-70.27%	-462.80%	1.07	1.45	32.70%	-873.10%	-813.97%
DRTS	ALPHA TAU MEDICAL LTD	$957.55M	-57.30%	-42.40%	-44.90%	-44.40%	0.37	7.45	N/A	N/A	N/A
VTGN	VISTAGEN THERAPEUTICS INC	$28.80M	-133.00%	-105.80%	-194.80%	-957.40%	0.37	3.67	100.00%	-5,491.30%	-5,490.78%
AMLX	AMYLYX PHARMACEUTICALS INC	$1.98B	-55.70%	-50.70%	-54.05%	-158.90%	0.08	17.85	N/A	N/A	N/A
ADCT	ADC THERAPEUTICS SA	$129.73M	N/A	-44.70%	-37.69%	-77.60%	-2.35	4.09	90.70%	-173.00%	-106.58%
AKBA	AKEBIA THERAPEUTICS INC	$305.81M	-62.70%	-5.70%	1.24%	5.70%	12.24	1.40	81.00%	-8.80%	1.01%
AVBP	ARRIVENT BIOPHARMA INC	$1.58B	-49.00%	-45.40%	-44.79%	-68.00%	0.08	13.95	N/A	N/A	N/A
CGON	CG ONCOLOGY INC	$6.35B	-23.30%	-22.20%	-16.98%	-24.20%	0.04	31.30	-50.00%	-3,682.60%	-3,682.61%
CTXR	CITIUS PHARMACEUTICALS INC	$14.82M	-67.40%	-34.80%	-58.28%	-62.80%	1.03	0.58	80.10%	-823.30%	-805.20%
TARA	PROTARA THERAPEUTICS INC	$231.56M	-38.70%	-36.00%	-34.59%	-44.50%	0.06	15.69	N/A	N/A	N/A
ALMS	ALUMIS INC	$3.37B	-54.60%	-43.50%	-40.95%	-67.30%	0.18	7.51	100.00%	-2,825.70%	-2,927.59%
SPRY	ARS PHARMACEUTICALS INC	$848.05M	-153.60%	-60.80%	-81.11%	-52.70%	3.69	4.94	74.10%	-200.00%	-194.99%
ODTX	ODYSSEY THERAPEUTICS INC	$867.45M	N/A	N/A	N/A	N/A	-0.09	8.33	N/A	N/A	N/A
EIKN	EIKON THERAPEUTICS INC	$619.89M	N/A	N/A	N/A	N/A	0.55	11.75	N/A	N/A	N/A
NMRA	NEUMORA THERAPEUTICS INC	$303.87M	-181.70%	-119.20%	-175.90%	-430.60%	1.18	5.10	N/A	N/A	N/A
ABCL	ABCELLERA BIOLOGICS INC	$2.25B	-14.90%	-10.60%	-14.11%	-14.50%	0.39	14.05	100.00%	-181.70%	-224.46%
CNTB	CONNECT BIOPHARMA HOLDINGS LTD	$137.89M	-122.30%	-97.10%	-149.73%	-482.50%	0.41	3.23	100.00%	-27,727.90%	-27,645.92%
VANI	VIVANI MEDICAL INC	$103.48M	-264.00%	-79.80%	-76.13%	-86.20%	1.22	3.18	N/A	N/A	N/A
COYA	COYA THERAPEUTICS INC	$129.01M	-57.30%	-50.10%	-42.48%	1,962.90%	0.09	15.02	100.00%	-266.10%	-266.07%
SION	SIONNA THERAPEUTICS INC	$1.90B	-27.30%	-25.90%	-28.98%	-31.10%	0.06	22.60	N/A	N/A	N/A
MTVA	METAVIA INC	$7.39M	-172.90%	-89.40%	-142.73%	213.00%	0.59	2.73	N/A	N/A	N/A
PYXS	PYXIS ONCOLOGY INC	$175.49M	-135.60%	-85.00%	-168.21%	-96.30%	1.06	2.76	82.80%	-589.80%	-579.80%
BCTX	BRIACELL THERAPEUTICS CORP	$26.62M	-155.10%	-130.60%	-134.00%	-411.10%	0.16	7.07	N/A	N/A	N/A
CTMX	CYTOMX THERAPEUTICS INC	$740.19M	-38.50%	-29.40%	-18.11%	-41.50%	0.12	10.38	100.00%	-174.80%	-165.74%
EWTX	EDGEWISE THERAPEUTICS INC	$4.46B	-32.50%	-31.00%	-35.49%	-35.10%	0.05	22.61	N/A	N/A	N/A
MPLT	MAPLIGHT THERAPEUTICS INC	$1.51B	N/A	N/A	N/A	N/A	0.05	22.91	N/A	N/A	N/A
EDIT	EDITAS MEDICINE INC	$279.03M	-677.40%	-58.20%	-101.07%	-167.00%	32.88	3.22	100.00%	-281.60%	-286.17%
NGNE	NEUROGENE INC	$506.13M	-37.90%	-34.70%	-40.38%	-52.40%	0.11	13.08	N/A	N/A	N/A
OBIO	ORCHESTRA BIOMED HOLDINGS INC	$253.89M	-158.10%	-60.40%	-60.37%	-73.50%	1.21	7.03	99.50%	-167.60%	-160.44%
TSHA	TAYSHA GENE THERAPIES INC	$1.82B	-56.10%	-40.20%	-46.32%	-220.10%	0.42	14.04	100.00%	-1,738.40%	-1,737.69%
ARTL	ARTELO BIOSCIENCES INC	$2.61M	-1,602.50%	-225.00%	-195.28%	324.80%	0.88	1.79	N/A	N/A	N/A
ACRV	ACRIVON THERAPEUTICS INC	$71.91M	-64.40%	-57.10%	-79.84%	-89.80%	0.13	8.98	N/A	N/A	N/A
CELC	CELCUITY INC	$4.87B	-244.60%	-50.20%	-45.85%	-34.30%	6.66	12.31	N/A	N/A	N/A
SYRE	SPYRE THERAPEUTICS INC	$7.63B	-31.20%	-27.80%	-26.43%	-36.20%	0.14	8.97	N/A	N/A	N/A
OCUL	OCULAR THERAPEUTIX INC	$2.15B	-64.60%	-48.40%	-40.72%	-296.40%	0.26	14.81	87.20%	-558.20%	-535.90%
FBLG	FIBROBIOLOGICS INC	$4.30M	-767.10%	-195.60%	-449.55%	-376.50%	1.28	1.59	N/A	N/A	N/A
PMN	PROMIS NEUROSCIENCES INC	$94.43M	-238.00%	-151.00%	-66.81%	761.30%	0.11	9.92	N/A	N/A	N/A
STOK	STOKE THERAPEUTICS INC	$1.99B	-48.80%	-42.30%	-46.04%	-74.00%	0.12	8.99	100.00%	-529.20%	-577.65%
CVKD	CADRENAL THERAPEUTICS INC	$8.75M	-411.00%	-275.60%	-661.53%	1,138.50%	0.59	2.68	N/A	N/A	N/A
IKT	INHIBIKASE THERAPEUTICS INC	$252.18M	-41.30%	-39.00%	-30.40%	-108.00%	0.03	30.14	N/A	N/A	N/A
ENGN	ENGENE THERAPEUTICS INC	$117.23M	-56.10%	-45.60%	-43.39%	-50.00%	0.21	12.57	N/A	N/A	N/A
OCS	OCULIS HOLDING AG	$744.50M	-56.80%	-45.60%	-47.03%	-99.90%	0.24	5.18	100.00%	-7,889.60%	-7,850.54%
KLRA	KAILERA THERAPEUTICS INC	$2.70B	N/A	N/A	N/A	N/A	-0.15	9.67	N/A	N/A	N/A
CYPH	CYPHERPUNK TECHNOLOGIES INC	$65.90M	-92.40%	-80.70%	-67.26%	-113.10%	0.04	27.28	N/A	N/A	N/A
CLNN	CLENE INC	$77.44M	N/A	-159.10%	-205.21%	-111.30%	-2.15	1.94	82.80%	-25,009.70%	-22,871.64%
LNAI	LUNAI BIOWORKS INC	$14.55M	N/A	-1,617.80%	1,355.58%	749.20%	-2.03	0.19	100.00%	-612,568.10%	-609,894.27%
ONCO	ONCONETIX INC	$1.12M	-109.00%	-51.10%	-77.94%	128.70%	0.26	1.41	79.60%	-1,364.20%	-1,247.44%
ALT	ALTIMMUNE INC	$548.42M	-42.60%	-35.60%	-27.25%	-51.40%	0.18	29.56	100.00%	-253,002.80%	-245,494.44%
RXRX	RECURSION PHARMACEUTICALS INC	$1.87B	-54.30%	-40.60%	-46.65%	-311.60%	0.31	5.47	7.20%	-842.90%	-849.83%
RCUS	ARCUS BIOSCIENCES INC	$3.90B	-69.00%	-35.30%	-45.56%	-51.60%	0.90	4.04	100.00%	-156.40%	-152.12%
INO	INOVIO PHARMACEUTICALS INC	$90.50M	-666.50%	-129.80%	-716.49%	2,404.00%	7.20	1.04	N/A	N/A	N/A
IMUX	IMMUNIC INC	$208.41M	-220.70%	-132.00%	-68.89%	407.30%	0.26	4.92	N/A	N/A	N/A
IMVT	IMMUNOVANT INC	$7.98B	-68.20%	-62.20%	-59.28%	4,013.20%	0.12	9.09	N/A	N/A	N/A
NERV	MINERVA NEUROSCIENCES INC	$203.59M	N/A	-662.80%	-463.54%	-601.20%	-1.35	17.65	N/A	N/A	N/A
DNLI	DENALI THERAPEUTICS INC	$4.06B	-52.20%	-43.90%	-43.94%	-54.40%	0.37	9.29	N/A	N/A	N/A
AVIR	ATEA PHARMACEUTICALS INC	$359.32M	-57.00%	-51.50%	-75.24%	-81.10%	0.14	7.89	N/A	N/A	N/A
DMAC	DIAMEDICA THERAPEUTICS INC	$352.94M	-77.20%	-69.30%	-74.22%	-90.40%	0.12	9.11	N/A	N/A	N/A
HUMA	HUMACYTE INC	$157.41M	-2,781.60%	-85.40%	-92.26%	-80.30%	8.51	3.93	-475.00%	-4,840.80%	-4,318.95%
PVLA	PALVELLA THERAPEUTICS INC	$2.13B	-56.90%	-42.50%	-16.46%	-633.60%	0.14	28.88	N/A	N/A	N/A
VRDN	VIRIDIAN THERAPEUTICS INC	$1.85B	-60.70%	-50.60%	-47.85%	-65.40%	0.24	15.15	100.00%	-508.50%	-497.44%
ARVN	ARVINAS INC	$516.17M	-44.40%	-28.40%	-41.57%	-41.20%	0.67	5.44	100.00%	-247.50%	-247.20%
SRRK	SCHOLAR ROCK HOLDING CORP	$6.56B	-163.50%	-96.70%	-84.39%	-216.20%	0.94	8.64	N/A	N/A	N/A
RARE	ULTRAGENYX PHARMACEUTICAL INC	$3.03B	N/A	-45.70%	-62.33%	-38.20%	-6.28	2.02	83.50%	-90.90%	-90.37%
ARTV	ARTIVA BIOTHERAPEUTICS INC	$237.77M	-73.20%	-62.70%	-91.58%	-77.10%	0.21	8.16	N/A	N/A	N/A
GNLX	GENELUX CORP	$128.69M	-174.60%	-123.60%	-133.79%	-207.60%	0.41	3.68	N/A	N/A	N/A
ABEO	ABEONA THERAPEUTICS INC	$319.74M	41.40%	29.50%	41.69%	57.30%	0.37	5.89	70.90%	454.90%	480.13%
RNAC	CARTESIAN THERAPEUTICS INC	$276.77M	N/A	-45.90%	-59.08%	-107.40%	-2.95	7.65	100.00%	-8,698.70%	-9,068.56%
CMND	CLEARMIND MEDICINE INC	$2.43M	-143.80%	-88.50%	-68.36%	694.30%	0.26	4.79	N/A	N/A	N/A
TNXP	TONIX PHARMACEUTICALS HOLDING CORP	$210.74M	-67.70%	-60.50%	-64.57%	-349.20%	0.14	6.99	58.60%	-839.50%	-839.52%
SPRB	SPRUCE BIOSCIENCES INC	$151.68M	-155.40%	-101.70%	-82.16%	1,096.50%	0.62	4.67	N/A	N/A	N/A
ZURA	ZURA BIO LTD	$508.24M	-76.80%	-65.90%	-34.39%	568.20%	0.05	19.33	N/A	N/A	N/A
CMPX	COMPASS THERAPEUTICS INC	$374.58M	-39.70%	-35.30%	-34.98%	-45.10%	0.10	19.04	N/A	N/A	N/A
PASG	PASSAGE BIO INC	$15.08M	-150.90%	-59.80%	-230.32%	-270.70%	2.10	1.73	N/A	N/A	N/A
LRMR	LARIMAR THERAPEUTICS INC	$380.21M	-134.10%	-96.00%	-103.27%	-449.60%	0.32	4.29	N/A	N/A	N/A
CRVS	CORVUS PHARMACEUTICALS INC	$1.13B	-38.90%	-35.70%	-18.32%	-44.40%	0.05	19.81	N/A	N/A	N/A
RVMD	REVOLUTION MEDICINES INC	$38.71B	-83.20%	-59.10%	-67.98%	-65.20%	0.50	6.80	N/A	N/A	N/A
GANX	GAIN THERAPEUTICS INC	$74.64M	-201.40%	-136.20%	-136.66%	1,668.10%	0.34	4.69	N/A	N/A	N/A
IRON	DISC MEDICINE INC	$2.86B	-36.90%	-33.90%	-33.06%	-39.40%	0.09	24.00	N/A	N/A	N/A
IMNM	IMMUNOME INC	$2.26B	-51.20%	-47.30%	-37.91%	-669.90%	0.05	21.68	100.00%	-5,593.80%	-5,593.85%
ACTU	ACTUATE THERAPEUTICS INC	$40.20M	-430.90%	-180.90%	-513.59%	372.90%	1.36	1.80	N/A	N/A	N/A
ZNTL	ZENTALIS PHARMACEUTICALS INC	$287.59M	-53.60%	-40.70%	-56.73%	-46.50%	0.39	6.19	N/A	N/A	N/A
CNTX	CONTEXT THERAPEUTICS INC	$53.29M	-60.00%	-54.80%	-76.88%	1,376.90%	0.13	8.96	N/A	N/A	N/A
CAPR	CAPRICOR THERAPEUTICS INC	$1.53B	-59.30%	-48.60%	-38.12%	-105.00%	0.17	8.42	N/A	N/A	N/A
ZBIO	ZENAS BIOPHARMA INC	$1.63B	-167.70%	-97.40%	-59.88%	-161.80%	1.23	11.94	N/A	N/A	N/A
AKTX	AKARI THERAPEUTICS PLC	$0.00	-123.30%	-63.00%	-141.42%	225.20%	1.36	0.27	N/A	N/A	N/A
MGX	METAGENOMI THERAPEUTICS INC	$47.06M	-51.20%	-36.60%	-49.32%	-40.60%	0.43	6.43	100.00%	-384.60%	-385.27%
NTLA	INTELLIA THERAPEUTICS INC	$2.33B	-57.30%	-46.10%	-57.83%	-56.60%	0.22	6.10	100.00%	-597.00%	-597.04%

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Jun 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Jazz Pharmaceuticals (NASDAQ:JAZZ)

Jazz Pharmaceuticals (NASDAQ:JAZZ) is the #1 top biotech stock out of 608 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Jazz Pharmaceuticals (NASDAQ:JAZZ) is: Value: A, Growth: A, Momentum: B, Sentiment: C, Safety: C, Financials: B, and AI: C.

Jazz Pharmaceuticals (NASDAQ:JAZZ) has a Due Diligence Score of 34, which is 10 points higher than the biotech industry average of 24.

JAZZ passed 11 out of 33 due diligence checks and has average fundamentals. Jazz Pharmaceuticals has seen its stock return 113.95% over the past year, overperforming other biotech stocks by 186 percentage points.

Jazz Pharmaceuticals has an average 1 year price target of $259.25, an upside of 12.71% from Jazz Pharmaceuticals's current stock price of $230.02.

Jazz Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 12 analysts covering Jazz Pharmaceuticals, 66.67% have issued a Strong Buy rating, 25% have issued a Buy, 8.33% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Immucell (NASDAQ:ICCC)

Immucell (NASDAQ:ICCC) is the #2 top biotech stock out of 608 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Immucell (NASDAQ:ICCC) is: Value: C, Growth: A, Momentum: B, Sentiment: C, Safety: C, Financials: B, and AI: B.

Immucell (NASDAQ:ICCC) has a Due Diligence Score of 19, which is -5 points lower than the biotech industry average of 24. Although this number is below the industry average, our proven quant model rates ICCC as a "A".

ICCC passed 6 out of 33 due diligence checks and has weak fundamentals. Immucell has seen its stock return 44.18% over the past year, overperforming other biotech stocks by 116 percentage points.

3. Exelixis (NASDAQ:EXEL)

Exelixis (NASDAQ:EXEL) is the #3 top biotech stock out of 608 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Exelixis (NASDAQ:EXEL) is: Value: A, Growth: B, Momentum: B, Sentiment: C, Safety: C, Financials: A, and AI: B.

Exelixis (NASDAQ:EXEL) has a Due Diligence Score of 45, which is 21 points higher than the biotech industry average of 24.

EXEL passed 15 out of 33 due diligence checks and has strong fundamentals. Exelixis has seen its stock return 27.11% over the past year, overperforming other biotech stocks by 99 percentage points.

Exelixis has an average 1 year price target of $49.44, a downside of -9.72% from Exelixis's current stock price of $54.77.

Exelixis stock has a consensus Buy recommendation according to Wall Street analysts. Of the 9 analysts covering Exelixis, 11.11% have issued a Strong Buy rating, 22.22% have issued a Buy, 66.67% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 7 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Centessa Pharmaceuticals (NASDAQ:CNTA)

Centessa Pharmaceuticals (NASDAQ:CNTA) has an annual dividend yield of 93.83%, which is 77 percentage points higher than the biotech industry average of 17.22%.

Centessa Pharmaceuticals's dividend payout ratio of 0% indicates that its high dividend yield might not be sustainable for the long-term.

2. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 33.28%, which is 16 percentage points higher than the biotech industry average of 17.22%.

Dominari Holdings's dividend payout ratio of -19.1% indicates that its high dividend yield might not be sustainable for the long-term.

3. Oramed Pharmaceuticals (NASDAQ:ORMP)

Oramed Pharmaceuticals (NASDAQ:ORMP) has an annual dividend yield of 5.35%, which is -12 percentage points lower than the biotech industry average of 17.22%.

Oramed Pharmaceuticals's dividend payout ratio of 9.4% indicates that its high dividend yield is sustainable for the long-term.

Why are biotech stocks up?

Biotech stocks were up 1.86% in the last day, and up 4.5% over the last week. Hemab Therapeutics Holdings was the among the top gainers in the biotechnology industry, gaining 16.77% yesterday.

Hemab Therapeutics Holdings shares are trading higher after the company announced it will present clinical and preclinical data from multiple blood coagulation programs at ISTH 2026.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Cormedix (NASDAQ:CRMD)

Cormedix (NASDAQ:CRMD) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Cormedix has a valuation score of 43, which is 31 points higher than the biotech industry average of 12. It passed 3 out of 7 valuation due diligence checks.

Cormedix's stock has dropped -47.53% in the past year. It has overperformed other stocks in the biotech industry by 24 percentage points.

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 57, which is 45 points higher than the biotech industry average of 12. It passed 4 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has gained 11.33% in the past year. It has overperformed other stocks in the biotech industry by 83 percentage points.

3. Biomarin Pharmaceutical (NASDAQ:BMRN)

Biomarin Pharmaceutical (NASDAQ:BMRN) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Biomarin Pharmaceutical has a valuation score of 29, which is 17 points higher than the biotech industry average of 12. It passed 2 out of 7 valuation due diligence checks.

Biomarin Pharmaceutical's stock has gained 9.06% in the past year. It has overperformed other stocks in the biotech industry by 81 percentage points.

Are biotech stocks a good buy now?

68.48% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 52.71% over the next year.

2.59% of biotech stocks have a Zen Rating of A (Strong Buy), 3.88% of biotech stocks are rated B (Buy), 45.26% are rated C (Hold), 36.64% are rated D (Sell), and 11.64% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is 16.11x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Jazz Pharmaceuticals (NASDAQ:JAZZ)

2. Immucell (NASDAQ:ICCC)

3. Exelixis (NASDAQ:EXEL)

1. Centessa Pharmaceuticals (NASDAQ:CNTA)

2. Dominari Holdings (NASDAQ:DOMH)

3. Oramed Pharmaceuticals (NASDAQ:ORMP)

1. Cormedix (NASDAQ:CRMD)

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

3. Biomarin Pharmaceutical (NASDAQ:BMRN)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBiotechnologyBest Biotech Stocks to Buy Now (2026)Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Jazz Pharmaceuticals (NASDAQ:JAZZ)

2. Immucell (NASDAQ:ICCC)

3. Exelixis (NASDAQ:EXEL)

1. Centessa Pharmaceuticals (NASDAQ:CNTA)

2. Dominari Holdings (NASDAQ:DOMH)

3. Oramed Pharmaceuticals (NASDAQ:ORMP)

1. Cormedix (NASDAQ:CRMD)

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

3. Biomarin Pharmaceutical (NASDAQ:BMRN)

Company

Stock Tools

Stock Ideas

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.